Following a comprehensive evaluation that includes both fundamental and technical analysis, as well as an in-depth assessment of prevailing investor sentiment and consultations with industry experts, it has become apparent that EYE is currently trading at a premium relative to its intrinsic value. Based on this analysis, I project that EYE will undergo a gradual correction towards its fair value, which I estimate to lie between $0.175 and $0.19. However, this price adjustment is unlikely to occur in a straightforward manner; rather, I anticipate a series of intermittent rallies and pullbacks as the stock price trends downwards towards these more sustainable levels.
Stonks92
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
Following a comprehensive evaluation that includes both...
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.3¢ |
Change
0.003(1.39%) |
Mkt cap ! $43.52M |
Open | High | Low | Value | Volume |
19.0¢ | 19.0¢ | 18.0¢ | $17.92K | 97.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 754 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 78269 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 754 | 0.180 |
4 | 137086 | 0.175 |
5 | 78850 | 0.170 |
4 | 114241 | 0.165 |
8 | 293300 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 78269 | 4 |
0.190 | 120204 | 4 |
0.200 | 93423 | 2 |
0.205 | 15050 | 1 |
0.215 | 304291 | 5 |
Last trade - 12.19pm 04/10/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |